239 related articles for article (PubMed ID: 28223316)
21. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
[TBL] [Abstract][Full Text] [Related]
22. Myeloid-derived suppressor cells and tumor escape from immune surveillance.
Umansky V; Blattner C; Fleming V; Hu X; Gebhardt C; Altevogt P; Utikal J
Semin Immunopathol; 2017 Apr; 39(3):295-305. PubMed ID: 27787613
[TBL] [Abstract][Full Text] [Related]
23. Myeloid-Derived Suppressor Cells in Sepsis.
Schrijver IT; Théroude C; Roger T
Front Immunol; 2019; 10():327. PubMed ID: 30873175
[TBL] [Abstract][Full Text] [Related]
24. The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative.
Karin N
Front Immunol; 2020; 11():557586. PubMed ID: 33193327
[TBL] [Abstract][Full Text] [Related]
25. Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor.
Yan D; Adeshakin AO; Xu M; Afolabi LO; Zhang G; Chen YH; Wan X
Front Immunol; 2019; 10():1399. PubMed ID: 31275326
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms overseeing myeloid-derived suppressor cell production in neoplastic disease.
Netherby CS; Abrams SI
Cancer Immunol Immunother; 2017 Aug; 66(8):989-996. PubMed ID: 28224211
[TBL] [Abstract][Full Text] [Related]
27. MiR-30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B-cell lymphoma.
Xu Z; Ji J; Xu J; Li D; Shi G; Liu F; Ding L; Ren J; Dou H; Wang T; Hou Y
FEBS J; 2017 Aug; 284(15):2410-2424. PubMed ID: 28605567
[TBL] [Abstract][Full Text] [Related]
28. Myeloid-Derived Suppressor Cells.
Gabrilovich DI
Cancer Immunol Res; 2017 Jan; 5(1):3-8. PubMed ID: 28052991
[TBL] [Abstract][Full Text] [Related]
29. Lipid Metabolism in Tumor-Associated Myeloid-Derived Suppressor Cells.
Liu W; Song H; Li X; Ren D; Ding S; Li Y
Adv Exp Med Biol; 2021; 1316():103-115. PubMed ID: 33740246
[TBL] [Abstract][Full Text] [Related]
30. Activated NKT cells facilitated functional switch of myeloid-derived suppressor cells at inflammation sites in fulminant hepatitis mice.
Wu D; Shi Y; Wang C; Chen H; Liu Q; Liu J; Zhang L; Wu Y; Xia D
Immunobiology; 2017 Feb; 222(2):440-449. PubMed ID: 27523745
[TBL] [Abstract][Full Text] [Related]
31. Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis.
Jian SL; Chen WW; Su YC; Su YW; Chuang TH; Hsu SC; Huang LR
Cell Death Dis; 2017 May; 8(5):e2779. PubMed ID: 28492541
[TBL] [Abstract][Full Text] [Related]
32. Myeloid-derived suppressor cells: paradoxical roles in infection and immunity.
Dai J; El Gazzar M; Li GY; Moorman JP; Yao ZQ
J Innate Immun; 2015; 7(2):116-26. PubMed ID: 25401944
[TBL] [Abstract][Full Text] [Related]
33. Metabolic Reprogramming of Myeloid-derived Suppressor Cells in the Tumor Microenvironment.
Liu L; Huo S; Liu J; Li Q; Wang J
Discov Med; 2021; 31(164):141-146. PubMed ID: 35188888
[TBL] [Abstract][Full Text] [Related]
34. The role of myeloid-derived suppressor cells in the pathogenesis of rheumatoid arthritis; anti- or pro-inflammatory cells?
Rajabinejad M; Salari F; Gorgin Karaji A; Rezaiemanesh A
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4149-4158. PubMed ID: 31698956
[TBL] [Abstract][Full Text] [Related]
35. Metabolic reprogramming of myeloid-derived suppressor cells in the context of organ transplantation.
Iske J; Cao Y; Roesel MJ; Shen Z; Nian Y
Cytotherapy; 2023 Aug; 25(8):789-797. PubMed ID: 37204374
[TBL] [Abstract][Full Text] [Related]
36. [Recombinant HMGB1 induces the differentiation of mouse myeloid cells into myeloid-derived suppressor cells in vitro].
Su Z; Zhang Y; Ni P; Wang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1362-1365. PubMed ID: 27667463
[TBL] [Abstract][Full Text] [Related]
37. Connections between Metabolism and Epigenetic Modification in MDSCs.
Dai H; Xu H; Wang S; Ma J
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027968
[TBL] [Abstract][Full Text] [Related]
38. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.
Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P
Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713
[TBL] [Abstract][Full Text] [Related]
39. The role of myeloid-derived suppressor cells (MDSC) in the inflammaging process.
Salminen A; Kaarniranta K; Kauppinen A
Ageing Res Rev; 2018 Dec; 48():1-10. PubMed ID: 30248408
[TBL] [Abstract][Full Text] [Related]
40. IL-17 inhibits the accumulation of myeloid-derived suppressor cells in breast cancer via activating STAT3.
Ma M; Huang W; Kong D
Int Immunopharmacol; 2018 Jun; 59():148-156. PubMed ID: 29655056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
